New Zealand · Delayed Price · Currency is NZD Infratil Earnings Call Transcripts
Fiscal Year 2026
-
A record-breaking contract with a U.S. hyperscaler boosts contracted capacity above 1 GW and secures nearly 100% investment-grade counterparties. EBITDAF is set to exceed AUD 1 billion in FY2028, with funding fully supported by existing debt and no new equity required. Sustainability, technological leadership, and a robust pipeline position the business for continued outsized growth.
-
Half-year results show 7% EBITDA growth, led by CDC and Longroad, with strong contract wins and asset divestments advancing strategic goals. Updated guidance reflects CDC at lower end and Longroad raised, while financial flexibility and sustainability credentials remain robust.
Fiscal Year 2025
-
The meeting reviewed strong financial performance, strategic asset moves, and board succession plans. Shareholders discussed management fees, portfolio concentration, and sustainability, with all resolutions—including director re-elections and fee payment options—passed by vote.
-
Proportionate EBITDA reached NZD 986 million, with portfolio value up 29% and strong growth in digital, renewables, and healthcare segments. FY2026 guidance targets up to NZD 1.05 billion EBITDA, with CDC and Longroad positioned for multi-year expansion.
-
Strong half-year results driven by CDC, 1NZ, and Wellington Airport, with EBITDA up 7% year-over-year and robust CapEx supporting future growth. Guidance narrowed, with CDC and Long Road facing timing and policy uncertainties, but overall outlook remains positive.
Fiscal Year 2024
-
The meeting highlighted a strong 30-year performance, robust FY24 results, and major investments in digital and renewables. Key initiatives include CDC data center expansion, One NZ's new offerings, and ongoing sustainability efforts. Shareholder engagement and governance remain priorities.